Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1/2 1

Status

Completed 2Withdrawn 1Terminated 1Active not recruiting 1

Sponsor Class

OTHER 5NIH 1INDUSTRY 1

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colonic Neoplasms 3Colorectal Neoplasms 2Polyps 1Fatigue 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × eicosapentaenoic acid ethyl ester × Clear all
NCT03428477 2025-04-18

EMT2

University of Leeds

Phase 3 Active not recruiting
418 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04682665 2024-12-04

Prebiotic Effect of Eicosapentaenoic Acid Treatment for Colorectal Cancer Liver Metastases

University of Leeds

Completed
81 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04216251 2024-05-03

PREPARE

Massachusetts General Hospital

Phase 1/2 Completed
81 enrolled 11 charts
Gastrointestinal

Colorectal Neoplasms

NCT03661047 2021-11-17

OMICC

Massachusetts General Hospital

Phase 2 Withdrawn
Gastrointestinal

Colonic Neoplasms, Polyps, Colorectal Neoplasms

NCT02940223 2021-06-10

Ethyl Icosapentate and Physical Activity in Treating Fatigue in Patients With Advanced Cancer

M.D. Anderson Cancer Center

Phase 2 Terminated
2 enrolled 6 charts

Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon âš¡